Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17619025 | PREVOTELLA PREPARATIONS AND TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND OTHER LUNG CONDITIONS | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17413861 | LACHNOSPIRACEAE MITIGATES AGAINST RADIATION-INDUCED HEMATOPOIETIC/GASTROINTESTINAL INJURY AND DEATH, AND PROMOTES CANCER CONTROL BY RADIATION | Final Rejection | The Regents of the University of Michigan |
| 17609495 | Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container | Final Rejection | Fresenius Medical Care Deutschland GmbH |
| 18268125 | COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME | Non-Final OA | Board of Regents, The University of Texas System |
| 17605283 | BONE-SPECIFIC COMPLEX COMPRISING BONE CELL TRANSFORMATION RECOMBINANT PROTEIN AND BONE-TARGETING MOLECULE | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17594643 | METABOLIC ENGINEERING OF NON-PATHOGENIC ESCHERICHIA COLI STRAINS FOR THE CONTROLLED PRODUCTION OF LOW MOLECULAR WEIGHT HEPAROSAN AND SIZE-SPECIFIC HEPAROSAN OLIGOSACCHARIDES | Final Rejection | University of Utah Research Foundation |
| 18869591 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | Final Rejection | ARIZONA BOARD OF REGENTS on behalf of the UNIVERSITY OF ARIZONA |
| 17493747 | Use Of A Mannanase Enzyme In Combination With Catechol Derivatives | Non-Final OA | Henkel AG & Co. KGaA |
| 18935724 | DIETARY EARLY GLYCATION PRODUCTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES | Final Rejection | University of Georgia Research Foundation, Inc. |
| 18488234 | BONE DISEASE TREATMENT | Non-Final OA | The University of Birmingham |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy